Literature DB >> 21725895

Genes potentially associated with cisplatin resistance of lung cancer cells.

K N Kashkin1, E A Musatkina, A V Komelkov, E A Tonevitsky, D A Sakharov, T V Vinogradova, E P Kopantsev, M V Zinovyeva, I A Favorskaya, Ya A Kainov, V N Aushev, I B Zborovskaya, A G Tonevitsky, E D Sverdlov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21725895     DOI： 10.1134/S1607672911030112

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  14 in total

1.  Chemosensitivity prediction by transcriptional profiling.

Authors:  J E Staunton; D K Slonim; H A Coller; P Tamayo; M J Angelo; J Park; U Scherf; J K Lee; W O Reinhold; J N Weinstein; J P Mesirov; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.

Authors:  Shingo Dan; Tatsuhiko Tsunoda; Osamu Kitahara; Rempei Yanagawa; Hitoshi Zembutsu; Toyomasa Katagiri; Kanami Yamazaki; Yusuke Nakamura; Takao Yamori
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

3.  I/NI-calls for the exclusion of non-informative genes: a highly effective filtering tool for microarray data.

Authors:  Willem Talloen; Djork-Arné Clevert; Sepp Hochreiter; Dhammika Amaratunga; Luc Bijnens; Stefan Kass; Hinrich W H Göhlmann
Journal:  Bioinformatics       Date:  2007-10-05       Impact factor: 6.937

4.  Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs.

Authors:  Takefumi Kikuchi; Yataro Daigo; Toyomasa Katagiri; Tatsuhiko Tsunoda; Koichi Okada; Soji Kakiuchi; Hitoshi Zembutsu; Yoichi Furukawa; Masafumi Kawamura; Koichi Kobayashi; Kohzoh Imai; Yusuke Nakamura
Journal:  Oncogene       Date:  2003-04-10       Impact factor: 9.867

5.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

6.  Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Authors:  Balazs Györffy; Paweł Surowiak; Olaf Kiesslich; Carsten Denkert; Reinhold Schäfer; Manfred Dietel; Hermann Lage
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

7.  Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Authors:  Chang-Qi Zhu; Keyue Ding; Dan Strumpf; Barbara A Weir; Matthew Meyerson; Nathan Pennell; Roman K Thomas; Katsuhiko Naoki; Christine Ladd-Acosta; Ni Liu; Melania Pintilie; Sandy Der; Lesley Seymour; Igor Jurisica; Frances A Shepherd; Ming-Sound Tsao
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

Review 8.  Molecular mechanisms of resistance and toxicity associated with platinating agents.

Authors:  Cara A Rabik; M Eileen Dolan
Journal:  Cancer Treat Rev       Date:  2006-11-03       Impact factor: 12.111

9.  Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.

Authors:  Cornelia Liedtke; Jing Wang; Attila Tordai; William F Symmans; Gabriel N Hortobagyi; Ludwig Kiesel; Kenneth Hess; Keith A Baggerly; Kevin R Coombes; Lajos Pusztai
Journal:  Breast Cancer Res Treat       Date:  2009-07-15       Impact factor: 4.872

10.  Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.

Authors:  Akihiko Gemma; Cai Li; Yuka Sugiyama; Kuniko Matsuda; Yoko Seike; Seiji Kosaihira; Yuji Minegishi; Rintaro Noro; Michiya Nara; Masahiro Seike; Akinobu Yoshimura; Aki Shionoya; Akiko Kawakami; Naoki Ogawa; Haruka Uesaka; Shoji Kudoh
Journal:  BMC Cancer       Date:  2006-06-30       Impact factor: 4.430
View more
  2 in total

1.  Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer.

Authors:  Anshika N Singh; Neeti Sharma
Journal:  Front Oncol       Date:  2020-04-08       Impact factor: 6.244

2.  Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captopril.

Authors:  Benjamin J Maldonato; Drake A Russell; Rheem A Totah
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.